This inventor holds 1 USPTO granted patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: Michael Hocker: Innovator in Urea Derivatives
Introduction
Michael Hocker is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on urea derivatives. His research focuses on developing compounds that can effectively inhibit the CCR-3 receptor, which is implicated in various diseases.
Latest Patents
Hocker holds a patent for "Urea derivatives as inhibitors for CCR-3 receptor." This patent describes how urea and thiourea derivatives can inhibit the cell function of the chemokine receptor CCR-3. These compounds present a promising approach for treating a range of diseases thought to be mediated by this receptor. The synthesis of these useful urea and thiourea derivatives can be achieved through both liquid and solid phase synthesis protocols. He has 1 patent to his name.
Career Highlights
Michael Hocker is currently employed at Kirin Beer Kabushiki Kaisha, where he continues to explore innovative solutions in his field. His work has the potential to impact therapeutic strategies for diseases associated with the CCR-3 receptor.
Collaborations
Hocker has collaborated with notable colleagues such as Hirohi Ohashi and Janak Padia. Their combined expertise contributes to the advancement of research in medicinal chemistry.
Conclusion
Michael Hocker's contributions to the field of urea derivatives and their application in inhibiting the CCR-3 receptor highlight his role as an innovative inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic development.